Maki Otsuka Selected Research

Maki Otsuka Research Topics

Disease

4	Lymphoma (Lymphomas) 12/2020 - 03/2009
3	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2016 - 01/2007
3	Neoplasms (Cancer) 12/2016 - 03/2009
3	Atherosclerosis 04/2015 - 09/2009
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2020 - 04/2018
2	Hemorrhage 03/2020 - 04/2018
2	Multiple Myeloma 01/2017 - 05/2016
2	Disease Progression 12/2016 - 05/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2015 - 01/2007
2	Atrial Fibrillation 04/2012 - 02/2009
2	Insulin Resistance 12/2011 - 09/2009
2	Hypertension (High Blood Pressure) 12/2011 - 10/2010
1	COVID-19 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2015
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2015
1	Obesity 04/2011
1	Sepsis (Septicemia) 12/2009
1	Critical Illness (Critically Ill) 12/2009
1	Carotid Artery Diseases 06/2008
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2007
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2007

Drug/Important Bio-Agent (IBA)

4	Dexamethasone (Maxidex)FDA LinkGeneric 03/2020 - 05/2016
3	Lenalidomide (CC 5013)FDA Link 01/2017 - 05/2016
2	Inosine Triphosphate (ITP)IBA 03/2020 - 04/2018
2	HDL CholesterolIBA 01/2011 - 09/2009
2	Antihypertensive Agents (Antihypertensives)IBA 10/2010 - 02/2009
1	AnticoagulantsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 12/2020
1	Prednisolone (Predate)FDA LinkGeneric 03/2020
1	mogamulizumabIBA 01/2018
1	Melphalan (Alkeran)FDA LinkGeneric 05/2016
1	Prednisone (Sone)FDA LinkGeneric 05/2016
1	Thalidomide (Thalomid)FDA Link 05/2016
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 04/2015
1	Alkylating AgentsIBA 01/2015
1	Podophyllotoxin (Condylox)FDA LinkGeneric 01/2015
1	AnthracyclinesIBA 01/2015
1	Troponin T (Troponin T1)IBA 04/2012
1	CholesterolIBA 01/2012
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2012
1	AldosteroneIBA 12/2011
1	GhrelinIBA 04/2011
1	oxidized low density lipoproteinIBA 01/2011
1	LDL CholesterolIBA 01/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2011
1	Endothelin-1 (Endothelin 1)IBA 10/2010
1	Proteins (Proteins, Gene)FDA Link 12/2009
1	HMGB1 Protein (HMG1)IBA 12/2009
1	Biomarkers (Surrogate Marker)IBA 09/2009
1	AcidsIBA 09/2009
1	Fibrinogen (Factor I)FDA Link 09/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2009
1	Triglycerides (Triacylglycerol)IBA 09/2009
1	CreatinineIBA 09/2009
1	C-Reactive ProteinIBA 09/2009
1	Insulin (Novolin)FDA Link 09/2009
1	AntigensIBA 03/2009
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 06/2008
1	Cladribine FDA LinkGeneric 08/2007

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2015
3	Drug Therapy (Chemotherapy) 12/2016 - 01/2007
2	Hematopoietic Stem Cell Transplantation 01/2021 - 01/2017
1	Combination Drug Therapy (Combination Chemotherapy) 01/2015
1	Aftercare (After-Treatment) 10/2007